International Journal of Bipolar Disorders · 2014 · 32 citations · 26 references
NursingPharmacotherapyPsychiatryCircadian RhythmsPsychiatric PharmacotherapyPsychopharmacologyBipolar Disorder PharmacotherapyBipolar DisordersCircadian Clock MechanismsCircadian DisruptionCircadian PharmacologyCircadian PhysiologyBiochemical RemissionCircadian ClocksCircadian Phase AssessmentLithium PharmacologyLithium TreatmentPeripheral Circadian BiomarkersRecurrence
Bipolar disorder (BD) is a common, severe mental disorder with a high recurrence rate. Lithium (Li) is the cornerstone of BD treatments to reduce recurrence, suicide, and mortality risks. However, only 30% of patients treated with Li achieve complete remission, and few markers of the response to treatment have yet been identified for application in routine practice. Circadian biomarkers may be relevant predictors of individual responses to Li because (1) Li has been shown to affect circadian rhythms, (2) disrupted circadian rhythms are a core expression of susceptibility to BD, and (3) circadian abnormalities during euthymia are associated with relapses.
26
Grand challenges in global mental health
Pamela Y. Collins, Vikram Patel, Sarah S. Joestl et al. · Nature · 2011 · 2.1K citations · Full text
GM Goodwin, I. Nicol Ferrier, JK Aronson et al. · Journal of Psychopharmacology · 2016 · 1.3K citations · Full text
Lakshmi N. Yatham, Sidney H. Kennedy, Sagar V. Parikh et al. · Bipolar Disorders · 2012 · 1.2K citations · Full text